Home
Renaissance

Renaissance Market Share Analysis for August 2026

Innovative oral, transdermal and intradermal drug delivery systems. We Care. We Create. We Deliver. Future-proof, non-invasive delivery technologies.

Industry: N/A

Domainrenpharm.com

Year Founded2000

Employees501 - 1000

Annual Revenue$100M - $200M

Renaissance

Renaissance (including company regionals)

renpharm.com

See more website traffic and engagement information

Renaissance Revenue up to August 2026 is 100M - 200M

revenue generated by Renaissance top domains

Renaissance top domains revenue over 3 years

Revenue for Renaissance top domains

renpharm.com100M - 200M

See more with Sales Intelligence

Total visits to Renaissance's top domains

Understand Renaissance market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

renpharm.com2.2K

See more with Sales Intelligence

Avg. visit duration in Renaissance's top domains

Analyze Renaissance engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

renpharm.com00:00:45

See more with Sales Intelligence

Avg. pageviews on Renaissance's top domains

See how Renaissance keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

renpharm.com1.92

See more with Sales Intelligence

Renaissance top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Renaissance

These are the website technologies, by industry, used by Renaissance top domains

Widget (6)

Twemoji

Advertising (5)

Google Adsense

Conversion & Analytics (4)

Google Analytics

Content Management System (3)

WordPress

More Technologies

9

See all

News & Signals from Renaissance

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsLTS Lohmann Therapie-Systeme AG acquires Renaissance Pharma Inc..LTS expands its CDMO capabilities with the acquisition of Renaissance Lakewood.

NewsTiziana Life Sciences plc partnered with Renaissance Pharma Inc. on Feb 21st '25.NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) - Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced a product development services agreement with Renaissance Lakewood LLC ("Renaissance"), a leading Contract Development and Manufacturing Organization (CDMO) focused on nasal drug delivery.

NewsRenaissance Pharma Inc. invested into assets: packaging lines on Sep 1st '24.To ensure the capacity to quickly respond to growing global market demands, Renaissance recently completed a campus expansion and also invested in two additional packaging lines, which will support the forecasted volumes for this important product while assuring ample capacity for other nasal sprays manufactured at Renaissance.